Researchers explored the effects of a telemedicine visit on care in patients with T1D.
Adolescence and emerging adulthood represent a complicated stage for patients with T1D. Access to mental health services during this transition is critical.
Both recent severe hypoglycemia (SH) and lifetime SH are associated with worse cognition among older adults with type 1 diabetes.
Patients with type 1 diabetes with optimal and suboptimal glycemic control differ with respect to clinical and health care utilization factors.
Intermittently scanned continuous glucose monitoring results in higher treatment satisfaction among adults with type 1 diabetes.
The approval was based on data from an active-controlled, treat-to-target trial (Onset7) that included 777 pediatric patients (aged 2 to 17 years) with type 1 diabetes.
For patients with type 1 diabetes, lipoprotein(a) [Lp(a)] is a significant risk factor for macrovascular disease, albuminuria, and calcified aortic valve disease.
Assessment of suicide risk as part of routine pediatric type 1 diabetes care is feasible and necessary.
The American Diabetes Association (ADA) has published an update to their Standards of Medical Care in Diabetes for 2020.
The risk for type 1 and type 2 diabetes from childhood into adulthood is increased in preterm-born individuals.
For women going through menopause, type 1 diabetes is associated with higher coronary artery calcium volume and accelerated progression of CAC over time.
The FDA has expanded the indication for Toujeo (insulin glargine; Sanofi) 300 Units/mL to include treatment of pediatric patients aged ≥6 years with diabetes mellitus.
The high prevalence of overweight and obesity in youth with T1D was consistent across a multinational cohort and persistent over time.
Adjusting glucose thresholds for hypoglycemia and hyperglycemia alarms in continuous glucose monitoring can help achieve better glucose control in patients with type 1 diabetes.
Medicaid expansion under the Affordable Care Act was found to improve self-reported diabetes management and self-reported health outcomes in patients with type 1 or type 2 diabetes.
Combination of cyclical pressure Topical Wound Oxygen (TWO2) therapy with optimal standard of care improves healing and can reduce recurrence of diabetic foot ulcer.
A closed-loop insulin delivery system, also referred to as an artificial pancreas, was found to be more effective than sensor-augmented insulin pump therapy in patients with type 1 diabetes.
The FDA has expanded the indication for Fiasp (insulin aspart injection; Novo Nordisk) 100 Units/mL to include use in insulin infusion pumps to improve glycemic control in adults with type 1 or type 2 diabetes.
For adults with type 1 diabetes, glycemic control may be worse than previously thought, and rates of all complications increase with increasing hemoglobin A1c.
Researchers assessed whether plasma copeptin, a surrogate marker of vasopressin, is associated with lower-extremity amputation in diabetes.